These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22034905)

  • 1. Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cells.
    Furuta K; Arao T; Sakai K; Kimura H; Nagai T; Tamura D; Aomatsu K; Kudo K; Kaneda H; Fujita Y; Matsumoto K; Yamada Y; Yanagihara K; Sekijima M; Nishio K
    Cancer Sci; 2012 Feb; 103(2):221-7. PubMed ID: 22034905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression and isoform variation analysis using Affymetrix Exon Arrays.
    Bemmo A; Benovoy D; Kwan T; Gaffney DJ; Jensen RV; Majewski J
    BMC Genomics; 2008 Nov; 9():529. PubMed ID: 18990248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.
    Duval A; Rolland S; Tubacher E; Bui H; Thomas G; Hamelin R
    Cancer Res; 2000 Jul; 60(14):3872-9. PubMed ID: 10919662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer.
    Rossi E; Klersy C; Manca R; Zuffardi O; Solcia E
    Hum Pathol; 2011 Dec; 42(12):1937-45. PubMed ID: 21676433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
    Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
    BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
    Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
    Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
    Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
    Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population.
    Yamada H; Shinmura K; Ito H; Kasami M; Sasaki N; Shima H; Ikeda M; Tao H; Goto M; Ozawa T; Tsuneyoshi T; Tanioka F; Sugimura H
    Cancer Sci; 2011 Oct; 102(10):1782-8. PubMed ID: 21777349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.
    Reiter JL; Threadgill DW; Eley GD; Strunk KE; Danielsen AJ; Sinclair CS; Pearsall RS; Green PJ; Yee D; Lampland AL; Balasubramaniam S; Crossley TD; Magnuson TR; James CD; Maihle NJ
    Genomics; 2001 Jan; 71(1):1-20. PubMed ID: 11161793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays.
    Yoshida R; Numata K; Imoto S; Nagasaki M; Doi A; Ueno K; Miyano S
    Genome Inform; 2006; 17(1):88-99. PubMed ID: 17503359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
    Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
    Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.
    Kunii K; Davis L; Gorenstein J; Hatch H; Yashiro M; Di Bacco A; Elbi C; Lutterbach B
    Cancer Res; 2008 Apr; 68(7):2340-8. PubMed ID: 18381441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer.
    Li XW; Shi BY; Yang QL; Wu J; Wu HM; Wang YF; Wu ZJ; Fan YM; Wang YP
    BMC Cancer; 2015 Dec; 15():954. PubMed ID: 26674321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.
    Asaoka Y; Tada M; Ikenoue T; Seto M; Imai M; Miyabayashi K; Yamamoto K; Yamamoto S; Kudo Y; Mohri D; Isomura Y; Ijichi H; Tateishi K; Kanai F; Ogawa S; Omata M; Koike K
    Biochem Biophys Res Commun; 2010 Apr; 394(4):1042-6. PubMed ID: 20331976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
    Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
    Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.